Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DK:NOVO/B
Recent news which mentions DK:NOVO/B
LifeMD’s stock soars 13% as company and Medifast to create weight-management program that includes GLP-1 drugs
December 13, 2023
Tickers
LFMD
LLY
MED
NVO
Tags
SPX
MED
DK:NOVO/B
From
MarketWatch
Walmart seems to have changed its view of weight-loss drugs
December 06, 2023
Tickers
GIS
K
KO
LLY
Tags
WMT
K
DK:NOVO/B
From
MarketWatch
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
December 04, 2023
Tickers
LLY
PFE
WMT
Tags
UK:AZN
WMT
PFE
From
MarketWatch
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
December 01, 2023
Tickers
LLY
NVO
PFE
SPX
Tags
DK:NOVO/B
SPX
PFE
From
MarketWatch
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
November 22, 2023
Tickers
AMGN
ARKK
BFIT
COMP
Tags
SPX
ARKK
LLY
From
MarketWatch
Hedge funds plow cash into top tech stocks leading to record levels of crowding
November 21, 2023
Tickers
AAPL
ABT
AMZN
GOOG
Tags
LLY
AAPL
TSLA
From
MarketWatch
British Land leads U.K. real estate stocks higher amid optimism on rents
November 13, 2023
Tags
UK:SGRO
UK:LAND
DK:NOVO/B
From
MarketWatch
Weight-loss drug maker reports 56% profit surge, as it continues to limit supplies
November 02, 2023
Tickers
LLY
NVO
Tags
LLY
NVO
DK:NOVO/B
From
MarketWatch
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
October 31, 2023
Tickers
ABBV
AMGN
LLY
NVO
Tags
NVO
LLY
AMGN
From
MarketWatch
Who is having the most influence over your money in 2023? Meet the MarketWatch 50.
October 31, 2023
Tickers
AAPL
AMZN
BRK-B
DVA
Tags
UPS
META
DVA
From
MarketWatch
The weight-loss drugs are coming for these companies — but here’s why Coke, others, may be spared, says JPMorgan
October 24, 2023
Tickers
A
AAPL
AMC
AVTR
Tags
TSLA
DASH
MMM
From
MarketWatch
Here’s what Ozempic, ASML and India’s fintech industry all have in common — and how one ETF takes advantage of all three
October 17, 2023
Tickers
ACWX
ASML
FERG
HDB
Tags
ASML
ACWX
NL:ASML
From
MarketWatch
What exactly are patients taking new weight-loss drugs eating and what are they avoiding? Bernstein asked them.
October 13, 2023
Tickers
CPB
GIS
HSY
K
Tags
SMPL
LLY
NVO
From
MarketWatch
DaVita plays down Ozempic’s potential in treating kidney disease
October 12, 2023
Tickers
DVA
SPX
Tags
SPX
DK:NOVO/B
DVA
From
MarketWatch
LVMH shares slump on sales miss, sending rival luxury-goods makers lower
October 11, 2023
Tags
XE:FME
DK:NOVO/B
UK:BP
From
MarketWatch
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
October 11, 2023
Tickers
FMS
LLY
NVS
Tags
DK:NOVO/B
XE:FME
FMS
From
MarketWatch
Coca-Cola and PepsiCo’s stocks fall after Walmart says weight-loss drugs have customers cutting back on calories
October 06, 2023
Tickers
LLY
NVO
PEP
SPX
Tags
NVO
PEP
LLY
From
MarketWatch
This fund shows that industry expertise can help you make a lot of money in the stock market
October 02, 2023
Tickers
ABBV
ABT
AKRO
ETNB
Tags
XBI
SPY
DK:NOVO/B
From
MarketWatch
Novo Nordisk, now Europe’s second-largest company by market cap, lifts outlook after 46% profit rise
August 10, 2023
Tickers
NVO
Tags
NVO
DK:NOVO/B
From
MarketWatch
Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes
August 09, 2023
Tickers
LLY
NVO
SPX
VKTX
Tags
DK:NOVO/B
NVO
XBI
From
MarketWatch
As obesity drugs help people eat less, these food companies could be the biggest losers
August 08, 2023
Tickers
ACI
BJ
BRBR
CAVA
Tags
YUM
CAVA
PEP
From
MarketWatch
Eli Lilly’s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook
August 08, 2023
Tickers
DJIA
JNJ
LLY
MRK
Tags
XPH
SPX
PFE
From
MarketWatch
Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults
August 08, 2023
Tickers
LLY
NVO
PFE
Tags
PFE
LLY
NVO
From
MarketWatch
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
July 21, 2023
Tickers
ALT
CTLT
GPCR
LLY
Tags
CH:BANB
XE:GXI
CTLT
From
MarketWatch
EU regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harm
July 11, 2023
Tickers
LLY
PFE
Tags
LLY
PFE
DK:NOVO/B
From
MarketWatch
Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid
June 29, 2023
Tickers
LLY
PFE
RAD
Tags
PFE
LLY
DK:NOVO/B
From
MarketWatch
Student-loan payments are coming back — and these are the stocks most at risk
June 20, 2023
Tickers
AAPL
AEO
AMC
BABA
Tags
AAPL
JP:8031
BX:TMUBMUSD10Y
From
MarketWatch
Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says
June 20, 2023
Tickers
LLY
NVO
Tags
DK:NOVO/B
LLY
NVO
From
MarketWatch
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
February 13, 2023
Tickers
ETNB
GNFT
ICPT
LLY
Tags
ICPT
TERN
DK:NOVO/B
From
MarketWatch
Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter
February 02, 2023
Tickers
LLY
SPX
Tags
DK:NOVO/B
SPX
LLY
From
MarketWatch
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.